<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS One</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40408365</article-id><article-id pub-id-type="pmc">PMC12101694</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0323885</article-id><article-id pub-id-type="publisher-id">PONE-D-24-22615</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical Elements</subject><subj-group><subject>Oxygen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Physical Activity</subject><subj-group><subject>Physical Fitness</subject><subj-group><subject>Exercise</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Sports Science</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Hyperoxia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Sports and Exercise Medicine</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Sports Science</subject><subj-group><subject>Sports and Exercise Medicine</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Flow</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Flow</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Blood</subject><subj-group><subject>Blood Flow</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Hypoxia</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Vascular Medicine</subject><subj-group><subject>Blood Pressure</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Muscles</subject><subj-group><subject>Skeletal Muscles</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Musculoskeletal System</subject><subj-group><subject>Muscles</subject><subj-group><subject>Skeletal Muscles</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Mild hyperbaric hyperoxia improves aerobic capacity and suppresses cardiopulmonary stress during the maximal cycle-ergometer test</article-title><alt-title alt-title-type="running-head">Mild hyperbaric hyperoxia and exercise tolerance</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hisamoto</surname><given-names>Kazufumi</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9405-8462</contrib-id><name><surname>Okubo</surname><given-names>Naoki</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Fujita</surname><given-names>Mako</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fukushima</surname><given-names>Hideki</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Okizuka</surname><given-names>Yoshinori</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yamanaka</surname><given-names>Takashi</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Matsui</surname><given-names>Tomoyuki</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Morihara</surname><given-names>Toru</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hojo</surname><given-names>Tatsuya</given-names></name><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fukuoka</surname><given-names>Yoshiyuki</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Takahashi</surname><given-names>Kenji</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Faculty of Health and Sports Science, Doshisha University, Kyoto, Japan,</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Marutamachi Rehabilitation Clinic, Kyoto, Japan</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Andreato</surname><given-names>Leonardo Vidal</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Amazonas State University, BRAZIL</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>nokubo@koto.kpu-m.ac.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>5</issue><elocation-id>e0323885</elocation-id><history><date date-type="received"><day>6</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>15</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 Hisamoto et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Hisamoto et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0323885.pdf">
</self-uri><abstract><p>Aerobic exercise is more recommended than anaerobic exercise for individuals with cardiopulmonary dysfunction to avoid cardiopulmonary stress. However, their oxygen-carrying capacity is already reduced, making it difficult to exercise enough. Therefore, we aimed to investigate whether mild hyperbaric hyperoxia enhances aerobic capacity and decreases cardiopulmonary stress during exercise with a particular focus on the ventilatory threshold (VT). Nineteen healthy men (age 34.9&#x02009;&#x000b1;&#x02009;10.8 years) performed ramp-loading tests on a cycle-ergometer under the three oxygen conditions: hypobaric hypoxia (HYPO; 0.7 ATA, 14.7% O<sub>2</sub>), normobaric normoxia (NOR; 1.0 ATA, 21% O<sub>2</sub>), and mild hyperbaric hyperoxia (HYPER; 1.3 ATA, 35% O<sub>2</sub>). Cardiopulmonary data were recorded using a gas exchange analyzer. VT was assessed based on minute ventilation (V<sub>E</sub>) using the V-slope method and the work rate on VT (W<sub>VT</sub>) was determined. Although the maximal values of V<sub>E</sub> did not differ among the oxygen conditions, W<sub>VT</sub> in the HYPER condition was significantly higher compared to others (HYPO; 125&#x02009;&#x000b1;&#x02009;21, NOR; 148&#x02009;&#x000b1;&#x02009;24, HYPER; 168&#x02009;&#x000b1;&#x02009;32 [W], each p&#x02009;&#x0003c;&#x02009;0.01). Systolic blood pressure and double product on VT in the HYPER condition were significantly reduced compared to others (HYPO; 172&#x02009;&#x000b1;&#x02009;21, 23096&#x02009;&#x000b1;&#x02009;4354, NOR; 173&#x02009;&#x000b1;&#x02009;15, 23377&#x02009;&#x000b1;&#x02009;3109, HYPER; 155&#x02009;&#x000b1;&#x02009;18, 21255&#x02009;&#x000b1;&#x02009;3340 [mmHg, beats&#x000b7;min<sup>-1</sup>&#x000b7;mmHg], each p&#x02009;&#x0003c;&#x02009;0.05). Although further clinical research targeting other populations is needed to apply mild hyperbaric hyperoxia in clinical practice, due to its positive effects on W<sub>VT</sub> and cardiopulmonary stress, the HYPER oxygen condition may potentially be used to enhance aerobic capacity and make individuals with cardiopulmonary dysfunction exercise safely.</p></abstract><funding-group><award-group id="award001"><funding-source><institution>JSPS KAKENHI</institution>
</funding-source><award-id>24K14301</award-id><principal-award-recipient>
<name><surname>Morihara</surname><given-names>Toru</given-names></name>
</principal-award-recipient></award-group><funding-statement>This work was supported by JSPS KAKENHI Grant Number 24K14301 (T Morihara). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"/><table-count count="2"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its <xref rid="sec018" ref-type="sec">Supporting Information</xref> files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its <xref rid="sec018" ref-type="sec">Supporting Information</xref> files.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>With the rapid aging of the population worldwide, an increasing number of elderly people have cardiopulmonary dysfunction and declined exercise tolerance [<xref rid="pone.0323885.ref001" ref-type="bibr">1</xref>&#x02013;<xref rid="pone.0323885.ref003" ref-type="bibr">3</xref>]. In clinical practice, aerobic exercise is recommended for elderly patients with cardiopulmonary dysfunction [<xref rid="pone.0323885.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0323885.ref006" ref-type="bibr">6</xref>], because cardiopulmonary stress is promoted under anaerobic metabolism [<xref rid="pone.0323885.ref007" ref-type="bibr">7</xref>]. The ventilatory threshold (VT) is defined as the turning point from aerobic to anaerobic metabolism [<xref rid="pone.0323885.ref008" ref-type="bibr">8</xref>]. Below the VT, sufficient oxygen is supplied to the skeletal working muscles, and the matching of O<sub>2</sub> supply and O<sub>2</sub> utilization is maintained. We attempted to increase the O<sub>2</sub> supply during exercise by raising atmospheric pressure and oxygen concentration.</p><p>Hyperbaric oxygen therapy is used for the treatment of various diseases such as carbon monoxide intoxication and decompression sickness and is generally set to 2.0 or more ATA (atmospheres absolute) and 100% O<sub>2</sub> concentrations. Barotrauma [<xref rid="pone.0323885.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0323885.ref010" ref-type="bibr">10</xref>], and restriction of pulmonary function [<xref rid="pone.0323885.ref011" ref-type="bibr">11</xref>] have occasionally been observed as adverse events related to this hyperbaric oxygen therapy. For the clinical rehabilitation of the elderly, adverse events due to excessive pressure and O<sub>2</sub> levels need to be avoided. Therefore, we focused on the oxygen condition (1.3 ATA, 35% O<sub>2</sub>), with a slight increase in atmospheric pressure and oxygen concentration. Oxygen conditions of 1.25&#x02013;1.3 ATA with 35&#x02013;40% O<sub>2</sub> have been defined as mild hyperbaric hyperoxia [<xref rid="pone.0323885.ref012" ref-type="bibr">12</xref>]. A previous study reported that exposure to this oxygen condition stimulated the parasympathetic nervous system in healthy individuals [<xref rid="pone.0323885.ref013" ref-type="bibr">13</xref>]. Parasympathetic excitation is expected to suppress hypertension and tachycardia, reducing cardiopulmonary stress. In another study, rat models of hypertension exposed to mild hyperbaric oxygen showed lower blood pressure than those kept under normoxia [<xref rid="pone.0323885.ref014" ref-type="bibr">14</xref>].</p><p>Parasympathetic excitation may help suppress an increase in blood pressure and cardiopulmonary stress, enabling safer exercises for individuals with cardiopulmonary dysfunction. We hypothesized that mild hyperbaric hyperoxia could help maintain aerobic metabolism during exercise without increasing cardiopulmonary stress.</p><p>However, given the lack of previous research on exercise under mild hyperbaric hyperoxia, it was essential first to evaluate its effects on cardiopulmonary function and safety in healthy individuals. Therefore, to clarify our hypothesis, this study investigated changes in aerobic metabolism and cardiopulmonary stress during maximal exercise in healthy participants.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Methods</title><sec id="sec003"><title>Participants</title><p>Nineteen healthy young and middle-aged male participants were enrolled in this study (age 34.9&#x02009;&#x000b1;&#x02009;10.8 years, height 172&#x02009;&#x000b1;&#x02009;5&#x02009;cm, weight 68.7&#x02009;&#x000b1;&#x02009;5.9&#x02009;kg, mean&#x02009;&#x000b1;&#x02009;standard deviation [SD]). They were medical professionals, including physical trainers and doctors. None of the participants had a history of chronic cardiopulmonary dysfunction.</p><p>After approval from the Ethics Committee of Marutamachi Hospital (IRB approval number: 01&#x02013;00021), participants were recruited, and informed written consent was obtained from all participants. Participants were recruited from November 1, 2021 to April 30, 2022. This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki for research involving human subjects.</p></sec><sec id="sec004"><title>Oxygen environments</title><p>The exercise tests were performed in customized barometric pressure-controlled chambers (2WAY-DX Free Space; W2500&#x02009;&#x000d7;&#x02009;D4000&#x02009;&#x000d7;&#x02009;H2600&#x02009;mm, Japan Press Bulk Ind., Shizuoka, Japan). The chamber was maintained at 25&#x000ba;C with 50% relative humidity. Three oxygen conditions were set: hypobaric hypoxia (HYPO; 0.7 ATA, 14.7% O<sub>2</sub>), normobaric normoxia (NOR; 1.0 ATA, 21% O<sub>2</sub>), and mild hyperbaric hyperoxia (HYPER; 1.3 ATA, 35% O<sub>2</sub>). The condition of 0.7 ATA is equivalent to an altitude of 3,000 m [<xref rid="pone.0323885.ref015" ref-type="bibr">15</xref>]. The HYPER condition was achieved by adjusting the rate of O<sub>2</sub> volume with an oxygen concentrator (ZYJ-10, Nanjing Careland Medical Equipment Co., Nanjing, China).</p></sec><sec id="sec005"><title>Maximal exercise protocol</title><p>The participants performed exercise load tests using a cycle ergometer (75XL-III; Konami, Tokyo, Japan) on 3 different days, with a 1-week interval between each test. The order of the three oxygen conditions was determined randomly and was not disclosed to the participants. The maximal exercise load test was performed on the cycle ergometer until the participant&#x02019;s exhaustion was observed. The gas analyzer mask was fitted to the participant&#x02019;s nose and mouth to ensure that there was no leakage from the sides of the mask.</p><p>The participants performed the exercise test on a cycle ergometer after three minutes of resting on the saddle (rest phase). The exercise load began at 20 watts (W) for four minutes (warm-up phase) and was increased by 20 W every minute until exhaustion was observed (ramp-protocol phase). The endpoint of the ramp protocol period was defined as the peak point. The peak work rate was defined as the maximum work rate (W<sub>max</sub>). After the peak point, the participants continued pedaling with unloading for one minute (recovery phase). The participants were encouraged to maintain a cadence of 60&#x02009;rpm with the assistance of a metronome throughout the maximal cycle ergometer test (<xref rid="pone.0323885.g001" ref-type="fig">Fig 1</xref>).</p><fig position="float" id="pone.0323885.g001"><object-id pub-id-type="doi">10.1371/journal.pone.0323885.g001</object-id><label>Fig 1</label><caption><title>The protocol of the maximal cycle-ergometer test.</title></caption><graphic xlink:href="pone.0323885.g001" position="float"/></fig></sec><sec id="sec006"><title>Measurements</title><sec id="sec007"><title>Pulmonary gas exchange response.</title><p>During the exercise test, pulmonary gas exchange variables were continuously monitored using a computerized online breath-by-breath measuring system (AE-310s; Minato Medical Sciences, Osaka, Japan). The metabolic chart was calibrated before each exercise test according to the manufacturer&#x02019;s recommendations. The breath-by-breath data were averaged every ten seconds.</p><p>The flow sensor of the AE-310s was a hot-wire velocimeter, and calibration was performed based on temperature, humidity, and atmospheric pressure. Flow meter calibration accuracy for the AE-310s was guaranteed under HYPO, NOR, and HYPER conditions. Therefore, minute ventilation (V<sub>E</sub>), tidal volume (TV), and breath frequency (BF) were measured under the three oxygen conditions. In contrast, gas meter calibration accuracy for the AE-310s was guaranteed only under 0.7&#x02013;1.05 ATA. Thus, the following measurements were taken only under the NOR condition: oxygen uptake (VO<sub>2</sub>), carbon dioxide elimination (VCO<sub>2</sub>), end-tidal O<sub>2</sub> pressure (P<sub>ET</sub>O<sub>2</sub>), and end-tidal CO<sub>2</sub> pressure (P<sub>ET</sub>CO<sub>2</sub>). Ventilatory equivalents of oxygen (V<sub>E</sub>/VO<sub>2</sub>), carbon dioxide (V<sub>E</sub>/VCO<sub>2</sub>), and oxygen pulse (VO<sub>2</sub>/HR) were calculated. Respiratory gas exchange ratio (R) was estimated by the equation &#x0201c;R=VCO<sub>2</sub>/VO<sub>2</sub>&#x0201d;, and used to evaluate whether maximal exercise was performed [<xref rid="pone.0323885.ref016" ref-type="bibr">16</xref>]. VO<sub>2max</sub> was automatically calculated as the maximum VO<sub>2</sub> value per body weight. V<sub>E</sub>/VCO<sub>2</sub> slope was also automatically calculated.</p></sec><sec id="sec008"><title>Cardiopulmonary response.</title><p>The heart rate (HR) and percutaneous O<sub>2</sub> saturation (SpO<sub>2</sub>) were recorded every minute by attaching a finger pulse oximeter (Deluxe SM-110; Santa Medical, CA, USA) to the participant&#x02019;s left second fingertip. Systolic and diastolic blood pressures (SBP and DBP) were recorded every minute using a manual Manchette sphygmomanometer (DS-45; Welch Allyn Japan, Tokyo, Japan) throughout the exercise test. As an index of cardiopulmonary stress, the double product (DP) was evaluated using the formula &#x0201c;DP = HR &#x000d7; SBP&#x0201d; [<xref rid="pone.0323885.ref017" ref-type="bibr">17</xref>]. The work rate relative to W<sub>max</sub> (%WR) was used to analyze the changes in cardiopulmonary responses during the exercise tests.</p></sec><sec id="sec009"><title>The criteria for termination.</title><p>In addition to the inability to maintain cadence, when a plateau or drop in VO<sub>2</sub>, HR&#x02009;&#x0003e;&#x02009;95% of the age-predicted maximum (220-age) [<xref rid="pone.0323885.ref018" ref-type="bibr">18</xref>], and severe hypoxemia (SpO<sub>2</sub>&#x02009;&#x0003c;&#x02009;80%) were observed, exercise tests were terminated.</p></sec><sec id="sec010"><title>The method of detecting VT.</title><p>A graph of the change in V<sub>E</sub> during the ramp protocol period (x-axis: time; y-axis: V<sub>E</sub>) was used to determine VT [<xref rid="pone.0323885.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0323885.ref020" ref-type="bibr">20</xref>]. Three examiners familiar with respiratory gas analysis determined two regression lines in the early and late phases of V<sub>E</sub> change. The intersection of the two regression lines was defined as the VT point (V-slope method) (<xref rid="pone.0323885.g002" ref-type="fig">Fig 2</xref>) [<xref rid="pone.0323885.ref021" ref-type="bibr">21</xref>]. The difference in the work rate on VT (W<sub>VT</sub>) among the three oxygen conditions was evaluated.</p><fig position="float" id="pone.0323885.g002"><object-id pub-id-type="doi">10.1371/journal.pone.0323885.g002</object-id><label>Fig 2</label><caption><title>Determination of the ventilatory threshold (VT) point.</title><p>The examiners determined two regression lines in the early and late phases of V<sub>E</sub> change. The inflection point of regression lines was defined as the VT point. Abbreviations: V<sub>E</sub>, minute ventilation; W<sub>max</sub>, maximal work rate.</p></caption><graphic xlink:href="pone.0323885.g002" position="float"/></fig></sec></sec><sec id="sec011"><title>Statistical analysis</title><p>All data were presented as means&#x02009;&#x000b1;&#x02009;SD. Statistical significance was set at p&#x02009;&#x0003c;&#x02009;0.05. Statistical analyses were performed using the SPSS 26.0 for Windows (IBM Corp., Armonk, NY, USA). One-way repeated analysis of variance (ANOVA) with Bonferroni&#x02019;s <italic toggle="yes">post-hoc</italic> test was used to identify differences among the three oxygen conditions. The changes in HR, SBP, DP, and SpO<sub>2</sub> were compared between the oxygen conditions (HYPO, NOR, and HYPER) and %WR (0&#x02013;100%) using repeated two-way ANOVA. Bonferroni&#x02019;s <italic toggle="yes">post-hoc</italic> test was applied to appropriate datasets if a significant <italic toggle="yes">F</italic>-value was obtained. We used a sample size determination program (PS: Power and Sample Size Calculation ver. 3.1.6 by D.D. William and D.P. Walton) to determine whether the sample size was adequate to detect differences among FIO<sub>2</sub> conditions. This study was designed to analyze a continuous response variable from matched pairs of participants. Since no studies have investigated exercise under hyperbaric hyperoxic conditions, we referred to a previous study on exercise under hypoxic conditions. In our previous study [<xref rid="pone.0323885.ref022" ref-type="bibr">22</xref>], the difference in the ventilatory threshold of matched pairs within two conditions (normoxia and 12% hypoxia) was normally distributed with an SD of 21.2 (W). If the true difference in the mean response of matched pairs was 49.0 (W), it was necessary to study at least 5 participants to reject the null hypothesis that this response difference was zero with the probability (power) value of 0.8. The probability of Type I error associated with this test of the null hypothesis was 0.01.</p></sec></sec><sec sec-type="results" id="sec012"><title>Results</title><sec id="sec013"><title>Validity of maximal exercise test under NOR condition</title><p>The cardiopulmonary variables at rest and peak under the NOR condition are summarized in <xref rid="pone.0323885.t001" ref-type="table">Table 1</xref>. At rest, HR was 70&#x02009;&#x000b1;&#x02009;9 beats&#x000b7;min<sup>-1</sup>, SBP was 120&#x02009;&#x000b1;&#x02009;10 mmHg, and SpO<sub>2</sub> was 98&#x02009;&#x000b1;&#x02009;1%. At peak, ramp-exercise time was 603&#x02009;&#x000b1;&#x02009;122 seconds, HR was 169&#x02009;&#x000b1;&#x02009;11 beats&#x000b7;min<sup>-1</sup>, SBP was 205&#x02009;&#x000b1;&#x02009;23 mmHg, and SpO<sub>2</sub> was 97&#x02009;&#x000b1;&#x02009;2%. R at peak was 1.11&#x02009;&#x000b1;&#x02009;0.06, indicating that all participants had performed the maximal exercise test [<xref rid="pone.0323885.ref023" ref-type="bibr">23</xref>]. VO<sub>2max</sub> was 43.9&#x02009;&#x000b1;&#x02009;9.3 mL&#x000b7;min<sup>-1</sup>&#x000b7;kg<sup>-1</sup>.</p><table-wrap position="float" id="pone.0323885.t001"><object-id pub-id-type="doi">10.1371/journal.pone.0323885.t001</object-id><label>Table 1</label><caption><title>Cardiopulmonary variables at rest and peak under the NOR condition.</title></caption><alternatives><graphic xlink:href="pone.0323885.t001" id="pone.0323885.t001g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">variables</th><th align="left" colspan="3" rowspan="1">rest</th><th align="left" colspan="3" rowspan="1">peak</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">V<sub>E</sub></td><td align="left" rowspan="1" colspan="1">(L&#x000b7;min<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">10.8</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">2.8</td><td align="left" rowspan="1" colspan="1">106.3</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">20.4</td></tr><tr><td align="left" rowspan="1" colspan="1">TV</td><td align="left" rowspan="1" colspan="1">(mL)</td><td align="left" rowspan="1" colspan="1">652</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">129</td><td align="left" rowspan="1" colspan="1">2208</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">328</td></tr><tr><td align="left" rowspan="1" colspan="1">BF</td><td align="left" rowspan="1" colspan="1">(breaths&#x000b7;min<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">16.6</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">3.8</td><td align="left" rowspan="1" colspan="1">49.1</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">11.1</td></tr><tr><td align="left" rowspan="1" colspan="1">ramp-load time</td><td align="left" rowspan="1" colspan="1">(second)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">603</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">122</td></tr><tr><td align="left" rowspan="1" colspan="1">W<sub>max</sub></td><td align="left" rowspan="1" colspan="1">(W)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">221</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">41</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(mL&#x000b7;min<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">319</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">2994</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">558</td></tr><tr><td align="left" rowspan="1" colspan="1">VO<sub>2max</sub></td><td align="left" rowspan="1" colspan="1">(mL&#x000b7;min<sup>-1</sup>&#x000b7;kg<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">43.9</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">9.3</td></tr><tr><td align="left" rowspan="1" colspan="1">VCO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(mL&#x000b7;min<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">235</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">3311</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">531</td></tr><tr><td align="left" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.74</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">0.10</td><td align="left" rowspan="1" colspan="1">1.11</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">V<sub>E</sub>/VO<sub>2</sub></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">34.3</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">9.4</td><td align="left" rowspan="1" colspan="1">35.7</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">4.1</td></tr><tr><td align="left" rowspan="1" colspan="1">V<sub>E</sub>/VCO<sub>2</sub></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">47.1</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">14.3</td><td align="left" rowspan="1" colspan="1">32.0</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">3.0</td></tr><tr><td align="left" rowspan="1" colspan="1">O<sub>2</sub> pulse</td><td align="left" rowspan="1" colspan="1">(mL&#x000b7;beats <sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">4.5</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">0.8</td><td align="left" rowspan="1" colspan="1">15.6</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">V<sub>E</sub>/VCO<sub>2</sub> slope</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">25.5</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" rowspan="1" colspan="1">P<sub>ET</sub>O<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="left" rowspan="1" colspan="1">15.0</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1">121.5</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">3.4</td></tr><tr><td align="left" rowspan="1" colspan="1">P<sub>ET</sub>CO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="left" rowspan="1" colspan="1">5.1</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">0.4</td><td align="left" rowspan="1" colspan="1">40.6</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">3.0</td></tr><tr><td align="left" rowspan="1" colspan="1">HR</td><td align="left" rowspan="1" colspan="1">(beats&#x000b7;min<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">70</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">169</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">11</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP</td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="left" rowspan="1" colspan="1">120</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">205</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP</td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="left" rowspan="1" colspan="1">83</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">10</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(%)</td><td align="left" rowspan="1" colspan="1">98</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">DP</td><td align="left" rowspan="1" colspan="1">(beats&#x000b7;min<sup>-1</sup>&#x000b7;mmHg)</td><td align="left" rowspan="1" colspan="1">8315</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">1267</td><td align="left" rowspan="1" colspan="1">34639</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">5660</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Values are presented as mean&#x02009;&#x000b1;&#x02009;standard deviation</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec014"><title>Cardiorespiratory response under the three oxygen conditions</title><p><xref rid="pone.0323885.g003" ref-type="fig">Fig 3</xref> shows the changes in HR, SBP, DP, and SpO<sub>2</sub> under the different oxygen conditions. HR under the HYPER condition was significantly lower compared to the NOR condition (range; 10&#x02013;40%WR, p&#x02009;&#x0003c;&#x02009;0.05) and HYPO condition (range; 10&#x02013;80%WR, p&#x02009;&#x0003c;&#x02009;0.05) (<xref rid="pone.0323885.g003" ref-type="fig">Fig 3A</xref>). Both SBP and DP were significantly lower under the HYPER condition compared to the other two oxygen conditions (range; 10&#x02013;100%WR, p&#x02009;&#x0003c;&#x02009;0.05) (<xref rid="pone.0323885.g003" ref-type="fig">Fig 3B</xref>, <xref rid="pone.0323885.g003" ref-type="fig">3C</xref>). The change in SpO<sub>2</sub> under the HYPER condition was significantly higher compared to the NOR condition (range; 0&#x02013;90%WR, p&#x02009;&#x0003c;&#x02009;0.05) and HYPO condition (range; 0&#x02013;100%WR, p&#x02009;&#x0003c;&#x02009;0.05) (<xref rid="pone.0323885.g003" ref-type="fig">Fig 3D</xref>). There was a significant difference in W<sub>max</sub> among the three conditions (HYPO; 202&#x02009;&#x000b1;&#x02009;36 W, NOR; 221&#x02009;&#x000b1;&#x02009;41 W, and HYPER; 225&#x02009;&#x000b1;&#x02009;43 W, p&#x02009;&#x0003c;&#x02009;0.01) (<xref rid="pone.0323885.t002" ref-type="table">Table 2</xref>, <xref rid="pone.0323885.g004" ref-type="fig">Fig 4A</xref>). W<sub>max</sub> under the HYPER condition was significantly higher than that under the HYPO condition (p&#x02009;&#x0003c;&#x02009;0.01), but not significantly different than that under the NOR condition (p&#x02009;=&#x02009;0.36). W<sub>max</sub> under the HYPO condition was significantly lower than that under the NOR condition (p&#x02009;&#x0003c;&#x02009;0.01). There were no significant differences in V<sub>E</sub>, TV, BF, and HR at peak among the three oxygen conditions. SBP, DBP, and DP at peak under the HYPER condition were significantly lower than those under the other oxygen conditions (p&#x02009;&#x0003c;&#x02009;0.01). SpO<sub>2</sub> at peak under the HYPER condition was significantly higher than that under the other oxygen conditions (p&#x02009;&#x0003c;&#x02009;0.01) (<xref rid="pone.0323885.t002" ref-type="table">Table 2</xref>).</p><table-wrap position="float" id="pone.0323885.t002"><object-id pub-id-type="doi">10.1371/journal.pone.0323885.t002</object-id><label>Table 2</label><caption><title>Cardiopulmonary variables at peak under the HYPO, NOR, and HYPER conditions.</title></caption><alternatives><graphic xlink:href="pone.0323885.t002" id="pone.0323885.t002g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">variables</th><th align="left" colspan="3" rowspan="1">HYPO</th><th align="left" colspan="3" rowspan="1">NOR</th><th align="left" colspan="3" rowspan="1">HYPER</th><th align="left" rowspan="1" colspan="1">p</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ramp-load time</td><td align="left" rowspan="1" colspan="1">(second)</td><td align="left" rowspan="1" colspan="1">546</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">108</td><td align="left" rowspan="1" colspan="1">603</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">122</td><td align="left" rowspan="1" colspan="1">614</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">128</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">W<sub>max</sub></td><td align="left" rowspan="1" colspan="1">(W)</td><td align="left" rowspan="1" colspan="1">202</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">36</td><td align="left" rowspan="1" colspan="1">221</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1">225</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">43</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">V<sub>E</sub></td><td align="left" rowspan="1" colspan="1">(L&#x000b7;min<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">110.4</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">20.9</td><td align="left" rowspan="1" colspan="1">106.3</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">20.4</td><td align="left" rowspan="1" colspan="1">103.1</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">17.9</td><td align="left" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" rowspan="1" colspan="1">TV</td><td align="left" rowspan="1" colspan="1">(ml)</td><td align="left" rowspan="1" colspan="1">2140</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">356</td><td align="left" rowspan="1" colspan="1">2208</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">328</td><td align="left" rowspan="1" colspan="1">2049</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">352</td><td align="left" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">BF</td><td align="left" rowspan="1" colspan="1">(breaths&#x000b7;min<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">52.1</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">8.8</td><td align="left" rowspan="1" colspan="1">49.1</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">11.1</td><td align="left" rowspan="1" colspan="1">51.6</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">12.4</td><td align="left" rowspan="1" colspan="1">0.52</td></tr><tr><td align="left" rowspan="1" colspan="1">HR</td><td align="left" rowspan="1" colspan="1">(beats&#x000b7;min<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">168</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">169</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">169</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">SBP</td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="left" rowspan="1" colspan="1">200</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">205</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">23</td><td align="left" rowspan="1" colspan="1">174</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">DBP</td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="left" rowspan="1" colspan="1">85</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">79</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">SpO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(%)</td><td align="left" rowspan="1" colspan="1">88</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">97</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">98</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">DP</td><td align="left" rowspan="1" colspan="1">(beats&#x000b7;min<sup>-1</sup>&#x000b7;mmHg)</td><td align="left" rowspan="1" colspan="1">33298</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">5014</td><td align="left" rowspan="1" colspan="1">34639</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">5660</td><td align="left" rowspan="1" colspan="1">27836</td><td align="left" rowspan="1" colspan="1">&#x000b1;</td><td align="left" rowspan="1" colspan="1">4444</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.01</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Values are presented as mean&#x02009;&#x000b1;&#x02009;standard deviation</p></fn></table-wrap-foot></table-wrap><fig position="float" id="pone.0323885.g003"><object-id pub-id-type="doi">10.1371/journal.pone.0323885.g003</object-id><label>Fig 3</label><caption><title>Comparison of the changes in HR (A), SBP (B), DP (C), and SpO2 (D) during maximal exercise test among the three oxygen conditions.</title><p>Values are mean&#x02009;&#x000b1;&#x02009;standard deviation. * NOR vs HYPER, # NOR vs HYPO, &#x02020; HYPER vs HYPO (p&#x02009;&#x0003c;&#x02009;0.05). The main effect of work rate (WR), the main effect of oxygen condition (Cond), and their interaction were presented. Abbreviations: HR, heart rate; SBP, systolic blood pressure; DP, double product; %WR, work rate relative to maximum work rate.</p></caption><graphic xlink:href="pone.0323885.g003" position="float"/></fig><fig position="float" id="pone.0323885.g004"><object-id pub-id-type="doi">10.1371/journal.pone.0323885.g004</object-id><label>Fig 4</label><caption><title>Comparison of W<sub>max</sub> (A), the changes in V<sub>E</sub> (B), and W<sub>VT</sub> (C) among the three oxygen conditions.</title><p>(A, C) Black dots show the data of each participant. Values are mean&#x02009;&#x000b1;&#x02009;standard deviation. *p&#x02009;&#x0003c;&#x02009;0.05, **p&#x02009;&#x0003c;&#x02009;0.01. (B) Values are mean&#x02009;&#x000b1;&#x02009;standard deviation. The main effect of work rate (WR), the main effect of oxygen condition (Cond), and their interaction were presented. Abbreviations: W<sub>max</sub>, maximal work rate; V<sub>E</sub>, minute ventilation; W<sub>VT</sub>, work rate on ventilatory threshold; ns, no significant difference; %WR, work rate relative to maximum work rate.</p></caption><graphic xlink:href="pone.0323885.g004" position="float"/></fig></sec><sec id="sec015"><title>VT under the three oxygen conditions</title><p>Even though there was no significant difference in V<sub>E</sub> during maximal exercise among the three oxygen conditions with two-way repeated ANOVA (<xref rid="pone.0323885.g004" ref-type="fig">Fig 4B</xref>), W<sub>VT</sub> was significantly higher under the HYPER condition (168&#x02009;&#x000b1;&#x02009;32 W) compared to the HYPO (125&#x02009;&#x000b1;&#x02009;21 W, p&#x02009;&#x0003c;&#x02009;0.01) and NOR (148&#x02009;&#x000b1;&#x02009;24 W, p&#x02009;&#x0003c;&#x02009;0.01) conditions (<xref rid="pone.0323885.g004" ref-type="fig">Fig 4C</xref>). Regarding cardiorespiratory response on VT, SpO<sub>2</sub> on VT was significantly higher under the HYPER condition (99.3&#x02009;&#x000b1;&#x02009;0.7%) compared to the HYPO (89.9&#x02009;&#x000b1;&#x02009;1.9%, p&#x02009;&#x0003c;&#x02009;0.01) and NOR conditions (97.4&#x02009;&#x000b1;&#x02009;1.0%, p&#x02009;&#x0003c;&#x02009;0.01) (<xref rid="pone.0323885.g005" ref-type="fig">Fig 5A</xref>). There was no significant difference in HR on VT among the three oxygen conditions (HYPO; 134&#x02009;&#x000b1;&#x02009;12 beats&#x000b7;min<sup>-1</sup>, NOR; 135&#x02009;&#x000b1;&#x02009;11 beats&#x000b7;min<sup>-1</sup>, HYPER; 137&#x02009;&#x000b1;&#x02009;10 beats&#x000b7;min<sup>-1</sup>) (<xref rid="pone.0323885.g005" ref-type="fig">Fig 5B</xref>). SBP on VT was significantly suppressed under the HYPER condition (155&#x02009;&#x000b1;&#x02009;18 mmHg) compared to the HYPO (172&#x02009;&#x000b1;&#x02009;21 mmHg, p&#x02009;&#x0003c;&#x02009;0.01) and NOR (173&#x02009;&#x000b1;&#x02009;15 mmHg, p&#x02009;&#x0003c;&#x02009;0.01) conditions (<xref rid="pone.0323885.g005" ref-type="fig">Fig 5C</xref>). Moreover, DP on VT under the HYPER condition (21255&#x02009;&#x000b1;&#x02009;3340 beats&#x000b7;min<sup>-1</sup>&#x000b7;mmHg) was significantly suppressed compared to the HYPO (23096&#x02009;&#x000b1;&#x02009;4354 beats&#x000b7;min<sup>-1</sup>&#x000b7;mmHg, p&#x02009;&#x0003c;&#x02009;0.05) and NOR (23377&#x02009;&#x000b1;&#x02009;3109 beats&#x000b7;min<sup>-1</sup>&#x000b7;mmHg, p&#x02009;&#x0003c;&#x02009;0.05) conditions (<xref rid="pone.0323885.g005" ref-type="fig">Fig 5D</xref>).</p><fig position="float" id="pone.0323885.g005"><object-id pub-id-type="doi">10.1371/journal.pone.0323885.g005</object-id><label>Fig 5</label><caption><title>Comparison of SpO<sub>2</sub> (A), HR (B), SBP (C), and DP (D) on VT among the three oxygen conditions.</title><p>Black dots show the data of each participant. Values are mean&#x02009;&#x000b1;&#x02009;standard deviation. *p&#x02009;&#x0003c;&#x02009;0.05, **p&#x02009;&#x0003c;&#x02009;0.01. Abbreviations: HR, heart rate; SBP, systolic blood pressure; DP, double product; VT, ventilatory threshold; ns, no significant difference.</p></caption><graphic xlink:href="pone.0323885.g005" position="float"/></fig></sec></sec><sec sec-type="conclusions" id="sec016"><title>Discussion</title><p>In this study, we evaluated the acute effects of the HYPER oxygen condition on aerobic capacity during maximal exercise tests in healthy individuals, with a particular focus on changes in the volume-related parameters and cardiopulmonary response. Although W<sub>max</sub> did not change under the HYPER condition compared with the NOR condition, W<sub>VT</sub> was significantly elevated under the HYPER condition compared with the NOR condition. Elevated W<sub>VT</sub> suggested that the HYPER condition enhanced the participants&#x02019; aerobic capacity. Furthermore, the suppression of cardiovascular stress, such as SBP and DP, on VT was observed under the HYPER condition.</p><p>The balance between the O<sub>2</sub> demand and supply in the skeletal muscle affects the determination of VT [<xref rid="pone.0323885.ref024" ref-type="bibr">24</xref>,<xref rid="pone.0323885.ref025" ref-type="bibr">25</xref>]. Even though the O<sub>2</sub> demand was expected to increase continually during the ramp protocol, W<sub>VT</sub> under the HYPER condition was higher than that under the other oxygen conditions, indicating that the O<sub>2</sub> supply to the working muscle was increased under the HYPER condition. The O<sub>2</sub> supply to working muscle was reported to be determined by arterial oxygen content (CaO<sub>2</sub>) &#x000d7; blood flow [<xref rid="pone.0323885.ref026" ref-type="bibr">26</xref>]. The oxygen in the blood is categorized into Hb-bound O<sub>2</sub> and non-bound O<sub>2</sub> (dissolved O<sub>2</sub>). Elevated SpO<sub>2</sub> levels during the exercise tests under the HYPER condition indicated that Hb-bound O<sub>2</sub> also increased. The dissolved O<sub>2</sub> under the HYPER condition was estimated to have increased because dissolved O<sub>2</sub> is proportional to the O<sub>2</sub> concentration and atmospheric pressure [<xref rid="pone.0323885.ref026" ref-type="bibr">26</xref>]. Based on the above discussion, under the HYPER condition, both Hb-bound O<sub>2</sub> and dissolved O<sub>2</sub> were increased, leading to an increase in CaO<sub>2</sub>. It has been reported that blood flow into working muscles is reduced under normobaric hyperoxia due to vasoconstriction [<xref rid="pone.0323885.ref026" ref-type="bibr">26</xref>]. This was because the expression of vasodilators such as nitric oxide (NO) [<xref rid="pone.0323885.ref027" ref-type="bibr">27</xref>] or prostaglandins (PG) [<xref rid="pone.0323885.ref028" ref-type="bibr">28</xref>] are suppressed under normobaric hyperoxia. Although blood flow was not directly evaluated in this study, hyperbaric hyperoxic conditions were estimated to induce high pressure on the peripheral organs and vessels, resulting in a greater reduction in blood flow than normobaric hyperoxia conditions. Therefore, the increased O<sub>2</sub> supply under the HYPER condition was mainly affected by an increase in CaO<sub>2</sub> rather than the change in blood flow. Under the HYPER condition, significant decreases in cardiopulmonary stress indicators were observed. This effect under the HYPER condition was regarded as the most notable benefit for the elderly to exercise more safely. Although the mechanism of the cardiovascular response under the HYPER condition remains unclear, it has been reported that exposure to hyperbaric hyperoxic conditions causes parasympathetic excitation [<xref rid="pone.0323885.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0323885.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0323885.ref030" ref-type="bibr">30</xref>].</p><p>Previous studies have demonstrated that exposure to hyperbaric hyperoxia (2.5 ATA, 100% O&#x02082;) during rest suppresses an increase in heart rate more effectively than normobaric hyperoxia (1.0 ATA, 100% O&#x02082;) [<xref rid="pone.0323885.ref031" ref-type="bibr">31</xref>]. Even with the same oxygen concentration, differences in atmospheric pressure may affect the degree of parasympathetic excitation. Regarding the effects of oxygen conditions during exercise, another study reported that normobaric hyperoxia (1.0 ATA, 60% O&#x02082;) did not significantly suppress the increase in heart rate in young women (28.1&#x02009;&#x000b1;&#x02009;9.2 years) during treadmill exercise [<xref rid="pone.0323885.ref032" ref-type="bibr">32</xref>]. In contrast, this study found that the HYPER condition suppressed cardiopulmonary stress during maximal exercise, suggesting that the pressurized environment played a role in this effect.</p><p>Both W<sub>max</sub> and W<sub>VT</sub> during exercise under the HYPO condition were reduced compared to those under the NOR condition, indicating that anaerobic metabolism started at a lower exercise load. As mentioned above, the O<sub>2</sub> supply to the working muscle was reported to be determined by CaO<sub>2</sub>&#x02009;&#x000d7;&#x02009;blood flow [<xref rid="pone.0323885.ref026" ref-type="bibr">26</xref>]. In this study, a decrease in SpO<sub>2</sub> during exercise was observed under the HYPO condition, indicating that CaO<sub>2</sub> was also reduced under this oxygen condition. The decrease in W<sub>VT</sub> under the HYPO condition suggested a reduction in the O<sub>2</sub> supply during exercise regardless of the change in blood flow. Previous studies have reported that exercise under hypobaric hypoxic conditions reduces the O<sub>2</sub> supply to skeletal working muscles [<xref rid="pone.0323885.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0323885.ref035" ref-type="bibr">35</xref>], which is consistent with our findings. Elevated HR, SBP, and DP throughout exercise under the HYPO condition were estimated as a compensatory response to the reduction in O<sub>2</sub> supply. In other words, cardiopulmonary stress increased during maximal exercise under the HYPO condition. These findings suggested that exercise under the HYPO condition may be beneficial for athletes and other healthy individuals to improve exercise performance because oxygen deficiency in skeletal muscles could lead to greater tolerance against hypoxia [<xref rid="pone.0323885.ref034" ref-type="bibr">34</xref>].</p><p>In clinical practice, exercise is recommended for patients with cardiopulmonary dysfunction to reduce the risk of cardiovascular events [<xref rid="pone.0323885.ref036" ref-type="bibr">36</xref>]. Exercise-induced hypertension is caused by sympathetic overexcitation [<xref rid="pone.0323885.ref037" ref-type="bibr">37</xref>] and is reported to cause organ damage, including left ventricular hypertrophy, atherosclerosis, and renal dysfunction [<xref rid="pone.0323885.ref038" ref-type="bibr">38</xref>]. A previous study reported that the frequency of hypertension during exercise was more observed in patients with cardiopulmonary disease than in healthy individuals [<xref rid="pone.0323885.ref039" ref-type="bibr">39</xref>]. Therefore, exercise load should be restricted to avoid exacerbating their cardiopulmonary disease. This restriction makes it difficult to provide adequate exercise load for patients with cardiopulmonary disease. Our findings suggest that mild hyperbaric hyperoxia could help exercise in patients with cardiopulmonary dysfunction by suppressing hypertension and tachycardia, reducing the risk of cardiovascular complications.</p><p>This study had some limitations. First, we did not directly evaluate blood flow during exercise tests. Further studies using near-infrared spectroscopy and doppler ultrasonography are required to clarify this issue. Second, there were variations in participant characteristics. The participants&#x02019; ages ranged from twenty-two to sixty years, and their cardiopulmonary functions varied among individuals. However, the wide distribution of these characteristics suggests that the results of this study may apply to other populations. Further clinical studies are needed to investigate the effects of exercise under the HYPER condition on individuals with cardiopulmonary dysfunction. Finally, only a single ramp-exercise protocol was employed in this study. Thus, further investigation is needed on ramp-exercise protocols with varying patterns and intensities.</p></sec><sec sec-type="conclusions" id="sec017"><title>Conclusions</title><p>Mild hyperbaric hyperoxia (1.3 ATA, 35% O&#x02082;) enhanced aerobic metabolism and reduced cardiopulmonary stress during maximal exercise tests. To the best of our knowledge, this is the first study to investigate the clinical benefits of exercise in a mildly hyperbaric hyperoxic environment. Although further clinical research is needed to apply mild hyperbaric hyperoxia in clinical practice, our findings suggested that exercise under a mild hyperbaric hyperoxic environment can be beneficial for individuals with cardiopulmonary dysfunction and may help them exercise safely.</p></sec><sec id="sec018" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0323885.s001" position="float" content-type="local-data"><label>S1 Dataset</label><caption><title>All data from the experiment.</title><p>(XLSX)</p></caption><media xlink:href="pone.0323885.s001.xlsx"/></supplementary-material></sec></body><back><ack><p>The authors thank the medical staff of Marutamachi Rehabilitation Clinic for their assistance in conducting this study. We also would like to thank Editage (<ext-link xlink:href="https://www.editage.com/" ext-link-type="uri">https://www.editage.com/</ext-link>) for English language editing.</p></ack><ref-list><title>References</title><ref id="pone.0323885.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Roger</surname><given-names>VL</given-names></name>. <article-title>Epidemiology of heart failure: a contemporary perspective</article-title>. <source>Circ Res</source>. <year>2021</year>;<volume>128</volume>(<issue>10</issue>):<fpage>1421</fpage>&#x02013;<lpage>34</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.318172</pub-id>
<pub-id pub-id-type="pmid">33983838</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Savarese</surname><given-names>G</given-names></name>, <name><surname>Becher</surname><given-names>PM</given-names></name>, <name><surname>Lund</surname><given-names>LH</given-names></name>, <name><surname>Seferovic</surname><given-names>P</given-names></name>, <name><surname>Rosano</surname><given-names>GMC</given-names></name>, <name><surname>Coats</surname><given-names>AJS</given-names></name>. <article-title>Global burden of heart failure: a comprehensive and updated review of epidemiology</article-title>. <source>Cardiovasc Res</source>. <year>2023</year>;<volume>118</volume>(<issue>17</issue>):<fpage>3272</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cvr/cvac013</pub-id>
<pub-id pub-id-type="pmid">35150240</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>von Haehling</surname><given-names>S</given-names></name>, <name><surname>Ebner</surname><given-names>N</given-names></name>, <name><surname>Dos Santos</surname><given-names>MR</given-names></name>, <name><surname>Springer</surname><given-names>J</given-names></name>, <name><surname>Anker</surname><given-names>SD</given-names></name>. <article-title>Muscle wasting and cachexia in heart failure: mechanisms and therapies</article-title>. <source>Nat Rev Cardiol</source>. <year>2017</year>;<volume>14</volume>(<issue>6</issue>):<fpage>323</fpage>&#x02013;<lpage>41</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrcardio.2017.51</pub-id>
<pub-id pub-id-type="pmid">28436486</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Lindgren</surname><given-names>M</given-names></name>, <name><surname>B&#x000f6;rjesson</surname><given-names>M</given-names></name>. <article-title>The importance of physical activity and cardiorespiratory fitness for patients with heart failure</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2021</year>;<volume>176</volume>:<fpage>108833</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.diabres.2021.108833</pub-id>
<pub-id pub-id-type="pmid">33895194</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>SJJ</given-names></name>, <name><surname>Allen</surname><given-names>JC</given-names></name>, <name><surname>Tan</surname><given-names>SY</given-names></name>. <article-title>Determination of ideal target exercise heart rate for cardiac patients suitable for rehabilitation</article-title>. <source>Clin Cardiol</source>. <year>2017</year>;<volume>40</volume>(<issue>11</issue>):<fpage>1008</fpage>&#x02013;<lpage>12</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/clc.22758</pub-id>
<pub-id pub-id-type="pmid">28683177</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Silva F de</surname><given-names>J</given-names></name>, <name><surname>Drummond</surname><given-names>FR</given-names></name>, <name><surname>Fidelis</surname><given-names>MR</given-names></name>, <name><surname>Freitas</surname><given-names>MO</given-names></name>, <name><surname>Leal</surname><given-names>TF</given-names></name>, <name><surname>de Rezende</surname><given-names>LMT</given-names></name>, <etal>et al</etal>. <article-title>Continuous aerobic exercise prevents detrimental remodeling and right heart myocyte contraction and calcium cycling dysfunction in pulmonary artery hypertension</article-title>. <source>J Cardiovasc Pharmacol</source>. <year>2021</year>;<volume>77</volume>(<issue>1</issue>):<fpage>69</fpage>&#x02013;<lpage>78</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/FJC.0000000000000928</pub-id>
<pub-id pub-id-type="pmid">33060546</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Hargens</surname><given-names>TA</given-names></name>, <name><surname>Griffin</surname><given-names>DC</given-names></name>, <name><surname>Kaminsky</surname><given-names>LA</given-names></name>, <name><surname>Whaley</surname><given-names>MH</given-names></name>. <article-title>The influence of aerobic exercise training on the double product break point in low-to-moderate risk adults</article-title>. <source>Eur J Appl Physiol</source>. <year>2011</year>;<volume>111</volume>(<issue>2</issue>):<fpage>313</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s00421-010-1661-x</pub-id>
<pub-id pub-id-type="pmid">20878176</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Dom&#x000ed;nguez</surname><given-names>R</given-names></name>, <name><surname>Mat&#x000e9;-Mu&#x000f1;oz</surname><given-names>JL</given-names></name>, <name><surname>Serra-Paya</surname><given-names>N</given-names></name>, <name><surname>Garnacho-Casta&#x000f1;o</surname><given-names>MV</given-names></name>. <article-title>Lactate threshold as a measure of aerobic metabolism in resistance exercise</article-title>. <source>Int J Sports Med</source>. <year>2018</year>;<volume>39</volume>(<issue>3</issue>):<fpage>163</fpage>&#x02013;<lpage>72</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1055/s-0043-122740</pub-id>
<pub-id pub-id-type="pmid">29284165</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>You</surname><given-names>J</given-names></name>, <name><surname>Ma</surname><given-names>H</given-names></name>, <name><surname>Zhou</surname><given-names>M</given-names></name>, <name><surname>Huang</surname><given-names>C</given-names></name>. <article-title>Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-analysis</article-title>. <source>BMJ Open</source>. <year>2023</year>;<volume>13</volume>(<issue>1</issue>):e062322. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmjopen-2022-062322</pub-id>
<pub-id pub-id-type="pmid">36690401</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>hadanny</surname><given-names>A</given-names></name>, <name><surname>Meir</surname><given-names>O</given-names></name>, <name><surname>Bechor</surname><given-names>Y</given-names></name>, <name><surname>Fishlev</surname><given-names>G</given-names></name>, <name><surname>Bergan</surname><given-names>J</given-names></name>, <name><surname>Efrati</surname><given-names>S</given-names></name>. <article-title>The safety of hyperbaric oxygen treatment--retrospective analysis in 2,334 patients</article-title>. <source>Undersea Hyperb Med</source>. <year>2016</year>;<volume>43</volume>(<issue>2</issue>):<fpage>113</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="pmid">27265988</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Demir</surname><given-names>L</given-names></name>, <name><surname>Avci</surname><given-names>M</given-names></name>. <article-title>Effect of hyperbaric exposure on pulmonary functions in hyperbaric chamber inside attendants</article-title>. <source>Undersea Hyperb Med</source>. <year>2022</year>;<volume>49</volume>(<issue>2</issue>):<fpage>161</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.22462/03.04.2022.1</pub-id>
<pub-id pub-id-type="pmid">35580483</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Ishihara</surname><given-names>A</given-names></name>. <article-title>Mild hyperbaric oxygen: mechanisms and effects</article-title>. <source>J Physiol Sci</source>. <year>2019</year>;<volume>69</volume>(<issue>4</issue>):<fpage>573</fpage>&#x02013;<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s12576-019-00678-5</pub-id>
<pub-id pub-id-type="pmid">31062232</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Nisa</surname><given-names>BU</given-names></name>, <name><surname>Hirabayashi</surname><given-names>T</given-names></name>, <name><surname>Maeshige</surname><given-names>N</given-names></name>, <name><surname>Kondo</surname><given-names>H</given-names></name>, <name><surname>Fujino</surname><given-names>H</given-names></name>. <article-title>Beneficial effects of mild hyperbaric oxygen exposure on microcirculation in peripheral tissues in healthy subjects: a pilot study</article-title>. <source>J Sports Med Phys Fitness</source>. <year>2022</year>;<volume>62</volume>(<issue>12</issue>):<fpage>1600</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.23736/S0022-4707.22.13363-3</pub-id>
<pub-id pub-id-type="pmid">35179329</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Nagatomo</surname><given-names>F</given-names></name>, <name><surname>Fujino</surname><given-names>H</given-names></name>, <name><surname>Takeda</surname><given-names>I</given-names></name>, <name><surname>Ishihara</surname><given-names>A</given-names></name>. <article-title>Effects of hyperbaric oxygenation on blood pressure levels of spontaneously hypertensive rats</article-title>. <source>Clin Exp Hypertens</source>. <year>2010</year>;<volume>32</volume>(<issue>3</issue>):<fpage>193</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/10641960903254521</pub-id>
<pub-id pub-id-type="pmid">20504127</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Karlsson</surname><given-names>LL</given-names></name>, <name><surname>Gustafsson</surname><given-names>LE</given-names></name>, <name><surname>Linnarsson</surname><given-names>D</given-names></name>. <article-title>Pulmonary nitric oxide in astronauts before and during long-term spaceflight</article-title>. <source>Front Physiol</source>. <year>2024</year>;<volume>15</volume>:<fpage>1298863</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fphys.2024.1298863</pub-id>
<pub-id pub-id-type="pmid">38357501</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Jarstad</surname><given-names>E</given-names></name>, <name><surname>Mamen</surname><given-names>A</given-names></name>. <article-title>The performance and aerobic endurance effects of high-intensity versus moderate-intensity continuous running</article-title>. <source>Appl Physiol Nutr Metab</source>. <year>2019</year>;<volume>44</volume>(<issue>9</issue>):<fpage>990</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1139/apnm-2018-0575</pub-id>
<pub-id pub-id-type="pmid">30726107</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Garc&#x000ed;a-Su&#x000e1;rez</surname><given-names>PC</given-names></name>, <name><surname>Renter&#x000ed;a</surname><given-names>I</given-names></name>, <name><surname>Garc&#x000ed;a Wong-Avil&#x000e9;s</surname><given-names>P</given-names></name>, <name><surname>Franco-Redona</surname><given-names>F</given-names></name>, <name><surname>G&#x000f3;mez-Miranda</surname><given-names>LM</given-names></name>, <name><surname>Aburto-Corona</surname><given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Hemodynamic adaptations induced by short-term run interval training in college students</article-title>. <source>Int J Environ Res Public Health</source>. <year>2020</year>;<volume>17</volume>(<issue>13</issue>):<fpage>4636</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijerph17134636</pub-id>
<pub-id pub-id-type="pmid">32605106</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Shookster</surname><given-names>D</given-names></name>, <name><surname>Lindsey</surname><given-names>B</given-names></name>, <name><surname>Cortes</surname><given-names>N</given-names></name>, <name><surname>Martin</surname><given-names>JR</given-names></name>. <article-title>Accuracy of commonly used age-predicted maximal heart rate equations</article-title>. <source>Int J Exerc Sci</source>. <year>2020</year>;<volume>13</volume>(<issue>7</issue>):<fpage>1242</fpage>&#x02013;<lpage>50</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.70252/XFSJ6815</pub-id>
<pub-id pub-id-type="pmid">33042384</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Ozkaya</surname><given-names>O</given-names></name>, <name><surname>Balci</surname><given-names>GA</given-names></name>, <name><surname>As</surname><given-names>H</given-names></name>, <name><surname>Yildiztepe</surname><given-names>E</given-names></name>. <article-title>A new technique to analyse threshold-intensities based on time dependent change-points in the ratio of minute ventilation and end-tidal partial pressure of carbon-dioxide production</article-title>. <source>Respir Physiol Neurobiol</source>. <year>2021</year>;<volume>294</volume>:<fpage>103735</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.resp.2021.103735</pub-id>
<pub-id pub-id-type="pmid">34229064</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Phillips</surname><given-names>DB</given-names></name>, <name><surname>Collins</surname><given-names>S&#x000c9;</given-names></name>, <name><surname>Stickland</surname><given-names>MK</given-names></name>. <article-title>Measurement and interpretation of exercise ventilatory efficiency</article-title>. <source>Front Physiol</source>. <year>2020</year>;<volume>11</volume>:<fpage>659</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fphys.2020.00659</pub-id>
<pub-id pub-id-type="pmid">32714201</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Glaab</surname><given-names>T</given-names></name>, <name><surname>Taube</surname><given-names>C</given-names></name>. <article-title>Practical guide to cardiopulmonary exercise testing in adults</article-title>. <source>Respir Res</source>. <year>2022</year>;<volume>23</volume>(<issue>1</issue>):<fpage>9</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12931-021-01895-6</pub-id>
<pub-id pub-id-type="pmid">35022059</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Fukuoka</surname><given-names>Y</given-names></name>, <name><surname>Endo</surname><given-names>M</given-names></name>, <name><surname>Oishi</surname><given-names>Y</given-names></name>, <name><surname>Ikegami</surname><given-names>H</given-names></name>. <article-title>Chemoreflex drive and the dynamics of ventilation and gas exchange during exercise at hypoxia</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2003</year>;<volume>168</volume>(<issue>9</issue>):<fpage>1115</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1164/rccm.2202027</pub-id>
<pub-id pub-id-type="pmid">14581289</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Guazzi</surname><given-names>M</given-names></name>, <name><surname>Adams</surname><given-names>V</given-names></name>, <name><surname>Conraads</surname><given-names>V</given-names></name>, <name><surname>Halle</surname><given-names>M</given-names></name>, <name><surname>Mezzani</surname><given-names>A</given-names></name>, <name><surname>Vanhees</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations</article-title>. <source>Eur Heart J</source>. <year>2012</year>;<volume>33</volume>(<issue>23</issue>):<fpage>2917</fpage>&#x02013;<lpage>27</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/eurheartj/ehs221</pub-id>
<pub-id pub-id-type="pmid">22952138</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Beaver</surname><given-names>WL</given-names></name>, <name><surname>Wasserman</surname><given-names>K</given-names></name>, <name><surname>Whipp</surname><given-names>BJ</given-names></name>. <article-title>A new method for detecting anaerobic threshold by gas exchange</article-title>. <source>J Appl Physiol (1985)</source>. <year>1986</year>;<volume>60</volume>(<issue>6</issue>):<fpage>2020</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/jappl.1986.60.6.2020</pub-id>
<pub-id pub-id-type="pmid">3087938</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref025"><label>25</label><mixed-citation publication-type="book">
<name><surname>Brinkman</surname><given-names>JE</given-names></name>, <name><surname>Toro</surname><given-names>F</given-names></name>, <name><surname>Sharma</surname><given-names>S</given-names></name>. <article-title>Physiology, Respiratory Drive. StatPearls. Treasure Island (FL) ineligible companies</article-title>. <article-title>Disclosure: Fadi Toro declares no relevant financial relationships with ineligible companies. Disclosure: Sandeep Sharma declares no relevant financial relationships with ineligible companies. Disclosure: Sandeep Sharma declares no relevant financial relationships with ineligible companies.</article-title>: StatPearls Publishing Copyright &#x000a9; 2024, <publisher-name>StatPearls Publishing LLC</publisher-name>.; <year>2024</year>.</mixed-citation></ref><ref id="pone.0323885.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Brugniaux</surname><given-names>JV</given-names></name>, <name><surname>Coombs</surname><given-names>GB</given-names></name>, <name><surname>Barak</surname><given-names>OF</given-names></name>, <name><surname>Dujic</surname><given-names>Z</given-names></name>, <name><surname>Sekhon</surname><given-names>MS</given-names></name>, <name><surname>Ainslie</surname><given-names>PN</given-names></name>. <article-title>Highs and lows of hyperoxia: physiological, performance, and clinical aspects</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>. <year>2018</year>;<volume>315</volume>(<issue>1</issue>):R1&#x02013;<lpage>27</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1152/ajpregu.00165.2017</pub-id>
<pub-id pub-id-type="pmid">29488785</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Taralds&#x000f8;y</surname><given-names>T</given-names></name>, <name><surname>Bolann</surname><given-names>BJ</given-names></name>, <name><surname>Thorsen</surname><given-names>E</given-names></name>. <article-title>Reduced nitric oxide concentration in exhaled gas after exposure to hyperbaric hyperoxia</article-title>. <source>Undersea Hyperb Med</source>. <year>2007</year>;<volume>34</volume>(<issue>5</issue>):<fpage>321</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="pmid">18019082</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Messina</surname><given-names>EJ</given-names></name>, <name><surname>Sun</surname><given-names>D</given-names></name>, <name><surname>Koller</surname><given-names>A</given-names></name>, <name><surname>Wolin</surname><given-names>MS</given-names></name>, <name><surname>Kaley</surname><given-names>G</given-names></name>. <article-title>Increases in oxygen tension evoke arteriolar constriction by inhibiting endothelial prostaglandin synthesis</article-title>. <source>Microvasc Res</source>. <year>1994</year>;<volume>48</volume>(<issue>2</issue>):<fpage>151</fpage>&#x02013;<lpage>60</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1006/mvre.1994.1046</pub-id>
<pub-id pub-id-type="pmid">7854203</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Nisa</surname><given-names>BU</given-names></name>, <name><surname>Nakanishi</surname><given-names>R</given-names></name>, <name><surname>Tanaka</surname><given-names>M</given-names></name>, <name><surname>Lin</surname><given-names>H</given-names></name>, <name><surname>Hirabayashi</surname><given-names>T</given-names></name>, <name><surname>Maeshige</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Mild hyperbaric oxygen exposure enhances peripheral circulatory natural killer cells in healthy young women</article-title>. <source>Life (Basel)</source>. <year>2023</year>;<volume>13</volume>(<issue>2</issue>):<fpage>408</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/life13020408</pub-id>
<pub-id pub-id-type="pmid">36836764</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Lund</surname><given-names>V</given-names></name>, <name><surname>Kentala</surname><given-names>E</given-names></name>, <name><surname>Scheinin</surname><given-names>H</given-names></name>, <name><surname>Klossner</surname><given-names>J</given-names></name>, <name><surname>Sariola-Heinonen</surname><given-names>K</given-names></name>, <name><surname>Jalonen</surname><given-names>J</given-names></name>. <article-title>Hyperbaric oxygen increases parasympathetic activity in professional divers</article-title>. <source>Acta Physiol Scand</source>. <year>2000</year>;<volume>170</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>44</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-201x.2000.00761.x</pub-id>
<pub-id pub-id-type="pmid">10971221</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Lund</surname><given-names>VE</given-names></name>, <name><surname>Kentala</surname><given-names>E</given-names></name>, <name><surname>Scheinin</surname><given-names>H</given-names></name>, <name><surname>Klossner</surname><given-names>J</given-names></name>, <name><surname>Helenius</surname><given-names>H</given-names></name>, <name><surname>Sariola-Heinonen</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Heart rate variability in healthy volunteers during normobaric and hyperbaric hyperoxia</article-title>. <source>Acta Physiol Scand</source>. <year>1999</year>;<volume>167</volume>(<issue>1</issue>):<fpage>29</fpage>&#x02013;<lpage>35</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1046/j.1365-201x.1999.00581.x</pub-id>
<pub-id pub-id-type="pmid">10519974</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Silva</surname><given-names>TC</given-names></name>, <name><surname>Aidar</surname><given-names>FJ</given-names></name>, <name><surname>Zanona A de</surname><given-names>F</given-names></name>, <name><surname>Matos</surname><given-names>DG</given-names></name>, <name><surname>Pereira</surname><given-names>DD</given-names></name>, <name><surname>Rezende</surname><given-names>PEN</given-names></name>, <etal>et al</etal>. <article-title>The Acute Effect of Hyperoxia on Onset of Blood Lactate Accumulation (OBLA) and Performance in Female Runners during the Maximal Treadmill Test</article-title>. <source>Int J Environ Res Public Health</source>. <year>2021</year>;<volume>18</volume>(<issue>9</issue>):<fpage>4546</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijerph18094546</pub-id>
<pub-id pub-id-type="pmid">33922940</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Mancera-Soto</surname><given-names>EM</given-names></name>, <name><surname>Chamorro-Acosta</surname><given-names>ML</given-names></name>, <name><surname>Ramos-Caballero</surname><given-names>DM</given-names></name>, <name><surname>Torrella</surname><given-names>JR</given-names></name>, <name><surname>Cristancho-Mej&#x000ed;a</surname><given-names>E</given-names></name>. <article-title>Effect of hypobaric hypoxia on hematological parameters related to oxygen transport, blood volume and oxygen consumption in adolescent endurance-training athletes</article-title>. <source>J Exerc Sci Fit</source>. <year>2022</year>;<volume>20</volume>(<issue>4</issue>):<fpage>391</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jesf.2022.10.003</pub-id>
<pub-id pub-id-type="pmid">36348710</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Lukanova-Jakubowska</surname><given-names>A</given-names></name>, <name><surname>Piechota</surname><given-names>K</given-names></name>, <name><surname>Grzywacz</surname><given-names>T</given-names></name>, <name><surname>Ambro&#x0017c;y</surname><given-names>T</given-names></name>, <name><surname>Rydzik</surname><given-names>&#x00141;</given-names></name>, <name><surname>Ozimek</surname><given-names>M</given-names></name>. <article-title>The impact of four high-altitude training camps on the aerobic capacity of a Short Track PyeongChang 2018 Olympian: a case study</article-title>. <source>Int J Environ Res Public Health</source>. <year>2022</year>;<volume>19</volume>(<issue>7</issue>):<fpage>3814</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/ijerph19073814</pub-id>
<pub-id pub-id-type="pmid">35409504</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Heikura</surname><given-names>IA</given-names></name>, <name><surname>Burke</surname><given-names>LM</given-names></name>, <name><surname>Bergland</surname><given-names>D</given-names></name>, <name><surname>Uusitalo</surname><given-names>ALT</given-names></name>, <name><surname>Mero</surname><given-names>AA</given-names></name>, <name><surname>Stellingwerff</surname><given-names>T</given-names></name>. <article-title>Impact of energy availability, health, and sex on hemoglobin-mass responses following live-high-train-high altitude training in elite female and male distance athletes</article-title>. <source>Int J Sports Physiol Perform</source>. <year>2018</year>;<volume>13</volume>(<issue>8</issue>):<fpage>1090</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1123/ijspp.2017-0547</pub-id>
<pub-id pub-id-type="pmid">29431548</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Hanssen</surname><given-names>H</given-names></name>, <name><surname>Boardman</surname><given-names>H</given-names></name>, <name><surname>Deiseroth</surname><given-names>A</given-names></name>, <name><surname>Moholdt</surname><given-names>T</given-names></name>, <name><surname>Simonenko</surname><given-names>M</given-names></name>, <name><surname>Kr&#x000e4;nkel</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on Hypertension</article-title>. <source>Eur J Prev Cardiol</source>. <year>2022</year>;<volume>29</volume>(<issue>1</issue>):<fpage>205</fpage>&#x02013;<lpage>15</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/eurjpc/zwaa141</pub-id>
<pub-id pub-id-type="pmid">33758927</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>D</given-names></name>, <name><surname>Ha</surname><given-names>J-W</given-names></name>. <article-title>Hypertensive response to exercise: mechanisms and clinical implication</article-title>. <source>Clin Hypertens</source>. <year>2016</year>;<volume>22</volume>:<fpage>17</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s40885-016-0052-y</pub-id>
<pub-id pub-id-type="pmid">27468357</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>MN</given-names></name>, <name><surname>Climie</surname><given-names>RE</given-names></name>, <name><surname>Otahal</surname><given-names>P</given-names></name>, <name><surname>Sharman</surname><given-names>JE</given-names></name>, <name><surname>Schultz</surname><given-names>MG</given-names></name>. <article-title>Exercise blood pressure and cardiac structure: a systematic review and meta-analysis of cross-sectional studies</article-title>. <source>J Sci Med Sport</source>. <year>2021</year>;<volume>24</volume>(<issue>9</issue>):<fpage>925</fpage>&#x02013;<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jsams.2021.02.014</pub-id>
<pub-id pub-id-type="pmid">33707155</pub-id>
</mixed-citation></ref><ref id="pone.0323885.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Xinwen</surname><given-names>L</given-names></name>, <name><surname>Cuicui</surname><given-names>Y</given-names></name>, <name><surname>Rongfang</surname><given-names>Z</given-names></name>, <name><surname>Jianmei</surname><given-names>Z</given-names></name>, <name><surname>Fang</surname><given-names>D</given-names></name>. <article-title>Correlation of exercise blood pressure levels with concomitant cardiovascular disease</article-title>. <source>Medicine (Baltimore)</source>. <year>2024</year>;<volume>103</volume>(<issue>43</issue>):e40226. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/MD.0000000000040226</pub-id>
<pub-id pub-id-type="pmid">39470564</pub-id>
</mixed-citation></ref></ref-list></back></article>